Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit — HEPSY  

Liver Fibrosis Clinical Trial

Official title: Acceptability of Advanced Chronic Liver Disease Screening by Transient Elstography (Fibroscan ®) in Patients Hospitalised in Psychiatric Unit: a Single Center Prospective Study

Status Not yet recruiting

Clinical Trial Summary

Scares data exists concerning the prevalence of chronic liver diseases in people with psychiatric disorders. There are still many barriers to screening and linkage to care for patients having somatic illness. Moreover follow-up of these patients may be difficult because of poor access to care, sometimes marginalization, and insufficient compliance with health programs. The aim of this study is to asses acceptability of of advanced chronic liver disease screening by transient elstography (Fibroscan ®) in patients hospitalised in a psychiatric unit.

Clinical Trial Description

Scares data exists concerning the prevalence of chronic liver diseases in people with psychiatric disorders. There are still many barriers to screening and linkage to care for patients having somatic illness. Moreover follow-up of these patients may be difficult because of poor access to care, sometimes marginalization, and insufficient compliance with health programs. Transient elastography is a useful tool validated for early diagnosis advanced chronic liver disease.It is non-invasive, fast, and gives immediate results. The aim of this study is to assess acceptability of of advanced chronic liver disease screening by transient elstography (Fibroscan ®) in patients hospitalised in psychiatric unit. Moreover, we will estimate de prevalence of advanced chronic liver diseases according to specific causes in psychiatry unit We hypothesize that the fact of offering psichiatric patents a non-invasive analysis of hepatic fibrosis will improve the detection of serious liver diseases and linkage to care. ;

Related Conditions & MeSH terms

• Advanced Chronic Liver Disease
• Liver Cirrhosis
• Liver Diseases
• Liver Fibrosis
• Mental Disorders
• Problem Behavior
• Psychiatric Disorder
• Psychiatric Hospitalization

• NCT number: NCT05602870
• Study type: Interventional
• Source: University Hospital, Montpellier
• Contact: Helene DONNADIEU, MD
• Phone: +334 67 33 70 20
• Email: h-donnadieu_rigole@chu-montpellier.fr
• Status: Not yet recruiting
• Phase: N/A
• Start date: December 1, 2022
• Completion date: December 1, 2024